|
Market Cap (10-Jun) $47,863,656 (0th) |
Close (30-Jun) $0.85 |
Volume (30-Jun) 942,590 |
Shortsold (27-Oct) 800,001 (0.58%) (257th) |
|
52w High $0.490 |
52w Low $0.312 |
P/E - |
EPS -0.06 |
IIQ released this announcement to the ASX on 25 November 2022, 9:18. The announcement is marked as price sensitive, and is 3 page(s) in length and 248.27kb in size.
You can view all announcements from IIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, IIQ was 0.002% short sold according to ASIC data. It was ranked the 630th most shorted stock on the ASX. It is now ranked as the 257th most shorted stock on the ASX with 0.576% of total shares short sold as of the latest reported data (27 October 2025).
| Other Recent Announcements from IIQ | |
|---|---|
| Notification of cessation of securities - IIQ | 30 June 2023, 14:19 |
| SubB2M/CA15.3 Clinical Validation Data Investor Presentation | 29 June 2023, 10:48 |
| INOVIQ Investor Briefing | 27 June 2023, 14:07 |
| Commercial and R&D Update | 25 November 2022, 9:18 |
| Healthcare Conference Investor Presentation | 10 November 2022, 11:28 |
| Appendix 4C - Statement pursuant to Listing Rule 4.7C.3 | 4 November 2022, 9:54 |
| IIQ Appendix 4C & Quarterly Activities Report-September 2022 | 28 October 2022, 9:53 |
You must be logged in to post a reply.
